東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back to Search results for [ null ]

Switch To: Labeled | MARC Mode | ISBD

The alpha and beta cardiac myosin he...

Yeshiva University.

Linked to FindBook

Google Book

Amazon

博客來

The alpha and beta cardiac myosin heavy chain isoforms direct mutation-specific effects on myofilament activation in Troponin-T related cardiomyopathies in vivo.

Record Type:	Electronic resources : Monograph/item
Title/Author:	The alpha and beta cardiac myosin heavy chain isoforms direct mutation-specific effects on myofilament activation in Troponin-T related cardiomyopathies in vivo./
Author:	Rice, Ron.
Description:	159 p.
Notes:	Adviser: Jil C. Tardiff.
Contained By:	Dissertation Abstracts International69-07B.
Subject:	Biology, Animal Physiology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3325523
ISBN:	9780549767060

The alpha and beta cardiac myosin heavy chain isoforms direct mutation-specific effects on myofilament activation in Troponin-T related cardiomyopathies in vivo.
Rice, Ron.

The alpha and beta cardiac myosin heavy chain isoforms direct mutation-specific effects on myofilament activation in Troponin-T related cardiomyopathies in vivo. - 159 p.

Adviser: Jil C. Tardiff.

Thesis (Ph.D.)--Yeshiva University, 2009.

Myofilament activation couples myocellular Ca2+ rise to thin filament sliding. Within the sarcomere, Troponin-T plays a central role in myofilament activation. Naturally occurring mutations of Troponin-T impair activation of the myofilaments and negatively affect contraction. Our R92Q and R92L transgenic models of cTnT related Familial Hypertrophic Cardiomyopathy (FHC) demonstrate impaired contraction/relaxation patterns and Ca2+ handling as well as myocyte disarray and fetal gene expression. Myofilament activation is not a fully Ca2+ regulated process but is enhanced by the cooperative binding of strong myosin crossbridges to the thin filament. Myosin, therefore, plays a central role in myofilament activation. Human ventricles predominantly express the beta myosin heavy chain isoform while smaller mammals, such as rodents, predominantly express alpha. The beta/alpha composition increases in human heart failure although the functional meaning of this change is unclear. To understand the role of increased beta-MyHC expression in the setting of a cardiomyopathy, we developed novel double transgenic mouse models expressing the R92Q or R92L cTnT mutation with 80% beta-MyHC in the left ventricle (LV). We therefore made a primary change in myofilament composition by increasing the number of cycling beta crossbridges in the context of cTnT mutations. Impaired R92Q whole heart and myocellular contractility improved in beta-R92Q double transgenics. Mutation specific improvements in myocellular Ca2+ handling were also noted and believed to drive the changes in contractility. Central to these changes was improved sarcoplasmic reticulum (SR) myocellular Ca2+ loading in beta-R92Q and beta-R92L isolated myocytes. Whole heart and myocellular contractility in R92L was consistent with Non-Tg and remained the same in beta-R92L double transgenics. Impaired SERCA2a mediated Ca2+ uptake in R92Q ventricular homogenates was rescued in beta-R92Q and was correlated with increased phosphorylated phospholamban (P-PLB). Conversely, beta-R92L homogenates demonstrated decreased P-PLB and Ca2+ uptake as compared to R92L, which was similar to Non-Tg in both respects. These observations demonstrate that increased beta-MyHC in the context of a cardiomyopathy, caused by thin filament missense mutations, results in mutation specific improvements in Ca2+ handling and contractility. We suggest these changes occurred via synergism between primary myofilament effects as well as posttranslational modifications.

ISBN: 9780549767060Subjects--Topical Terms:

1017835
Biology, Animal Physiology.

The alpha and beta cardiac myosin heavy chain isoforms direct mutation-specific effects on myofilament activation in Troponin-T related cardiomyopathies in vivo.
LDR:03475nmm 2200277 a 45 001 867307
005 20100804
008 100804s2009 ||||||||||||||||| ||eng d
020 $a 9780549767060
035 $a (UMI)AAI3325523
035 $a AAI3325523
040 $a UMI $c UMI
100 1 $a Rice, Ron. $3 1036030
245 1 4 $a The alpha and beta cardiac myosin heavy chain isoforms direct mutation-specific effects on myofilament activation in Troponin-T related cardiomyopathies in vivo.
300 $a 159 p.
500 $a Adviser: Jil C. Tardiff.
500 $a Source: Dissertation Abstracts International, Volume: 69-07, Section: B, page: 3926.
502 $a Thesis (Ph.D.)--Yeshiva University, 2009.
520 $a Myofilament activation couples myocellular Ca2+ rise to thin filament sliding. Within the sarcomere, Troponin-T plays a central role in myofilament activation. Naturally occurring mutations of Troponin-T impair activation of the myofilaments and negatively affect contraction. Our R92Q and R92L transgenic models of cTnT related Familial Hypertrophic Cardiomyopathy (FHC) demonstrate impaired contraction/relaxation patterns and Ca2+ handling as well as myocyte disarray and fetal gene expression. Myofilament activation is not a fully Ca2+ regulated process but is enhanced by the cooperative binding of strong myosin crossbridges to the thin filament. Myosin, therefore, plays a central role in myofilament activation. Human ventricles predominantly express the beta myosin heavy chain isoform while smaller mammals, such as rodents, predominantly express alpha. The beta/alpha composition increases in human heart failure although the functional meaning of this change is unclear. To understand the role of increased beta-MyHC expression in the setting of a cardiomyopathy, we developed novel double transgenic mouse models expressing the R92Q or R92L cTnT mutation with 80% beta-MyHC in the left ventricle (LV). We therefore made a primary change in myofilament composition by increasing the number of cycling beta crossbridges in the context of cTnT mutations. Impaired R92Q whole heart and myocellular contractility improved in beta-R92Q double transgenics. Mutation specific improvements in myocellular Ca2+ handling were also noted and believed to drive the changes in contractility. Central to these changes was improved sarcoplasmic reticulum (SR) myocellular Ca2+ loading in beta-R92Q and beta-R92L isolated myocytes. Whole heart and myocellular contractility in R92L was consistent with Non-Tg and remained the same in beta-R92L double transgenics. Impaired SERCA2a mediated Ca2+ uptake in R92Q ventricular homogenates was rescued in beta-R92Q and was correlated with increased phosphorylated phospholamban (P-PLB). Conversely, beta-R92L homogenates demonstrated decreased P-PLB and Ca2+ uptake as compared to R92L, which was similar to Non-Tg in both respects. These observations demonstrate that increased beta-MyHC in the context of a cardiomyopathy, caused by thin filament missense mutations, results in mutation specific improvements in Ca2+ handling and contractility. We suggest these changes occurred via synergism between primary myofilament effects as well as posttranslational modifications.
590 $a School code: 0266.
650 4 $a Biology, Animal Physiology. $3 1017835
650 4 $a Biology, Molecular. $3 1017719
690 $a 0307
690 $a 0433
710 2 $a Yeshiva University. $3 1017732
773 0 $t Dissertation Abstracts International $g 69-07B.
790 $a 0266
790 1 0 $a Tardiff, Jil C., $e advisor
791 $a Ph.D.
792 $a 2009
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3325523